These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7497464)

  • 1. Peritoneal exfoliative cytology and Ki-ras mutational analysis in patients with pancreatic adenocarcinoma.
    Rall CJ; Rivera JA; Centeno BA; Fernandez-del Castillo C; Rattner DW; Warshaw AL; Rustgi AK
    Cancer Lett; 1995 Nov; 97(2):203-11. PubMed ID: 7497464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of c-Ki-ras gene codon 12 mutations from pancreatic duct brushings in the diagnosis of pancreatic tumours.
    Van Laethem JL; Vertongen P; Deviere J; Van Rampelbergh J; Rickaert F; Cremer M; Robberecht P
    Gut; 1995 May; 36(5):781-7. PubMed ID: 7797131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymerase chain reaction-based K-ras mutation detection of pancreatic adenocarcinoma in routine cytology smears.
    Apple SK; Hecht JR; Novak JM; Nieberg RK; Rosenthal DL; Grody WW
    Am J Clin Pathol; 1996 Mar; 105(3):321-6. PubMed ID: 8602613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of c-Ki-ras mutation by PCR/RFLP analysis and diagnosis of pancreatic adenocarcinomas.
    Urban T; Ricci S; Grange JD; Lacave R; Boudghene F; Breittmayer F; Languille O; Roland J; Bernaudin JF
    J Natl Cancer Inst; 1993 Dec; 85(24):2008-12. PubMed ID: 7902444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-Ki-ras mutations in peripheral blood of pancreatic cancer patients: a marker for early tumor metastasis.
    Mohiuddin M; Ahmed MM; Venkatasubbarao K
    Int J Radiat Oncol Biol Phys; 1996 Jan; 34(1):161-6. PubMed ID: 12118546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical application of K-ras oncogene mutations in pancreatic carcinoma: detection of micrometastases.
    Nomoto S; Nakao A; Ando N; Takeda S; Kasai Y; Inoue S; Kaneko T; Takagi H
    Semin Surg Oncol; 1998; 15(1):40-6. PubMed ID: 9671955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of minute cancer cell dissemination in peritoneal lavage fluid detected by reverse transcription PCR is an independent prognostic factor in patients with resectable pancreatic cancer.
    Eguchi H; Ohigashi H; Takahashi H; Yano M; Motoori M; Miyashiro I; Kishi K; Ohue M; Noura S; Seki Y; Yamada T; Goto K; Yamamoto T; Idota A; Fujii J; Nakajima H; Yamasaki T; Ishikawa O
    Surgery; 2009 Nov; 146(5):888-95. PubMed ID: 19744431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Peritoneal Staging for Pancreatic Ductal Adenocarcinoma Using Mutant KRAS Droplet-Digital Polymerase Chain Reaction: Results of a Prospective Clinical Trial.
    Yonkus JA; Alva-Ruiz R; Abdelrahman AM; Leiting JL; Schneider AR; Grotz TE; Cleary SP; Smoot RL; Nagorney DM; Kendrick ML; Kipp BR; Truty MJ
    J Am Coll Surg; 2021 Jul; 233(1):73-80.e1. PubMed ID: 34022414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ki-ras codon 12 point and P53 mutations: a molecular examination of the main tumor, liver, portal vein, peripheral arterial blood and para-aortic lymph node in pancreatic cancer.
    Yamaguchi K; Chijiiwa K; Torato N; Kinoshita M; Tanaka M
    Am J Gastroenterol; 2000 Aug; 95(8):1939-45. PubMed ID: 10950039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of RT-PCR-based detection of peritoneal micrometastases in patients with pancreatic cancer undergoing curative resection.
    Kelly KJ; Wong J; Gladdy R; Moore-Dalal K; Woo Y; Gonen M; Brennan M; Allen P; Fong Y; Coit D
    Ann Surg Oncol; 2009 Dec; 16(12):3333-9. PubMed ID: 19763694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of mutant K-ras in dissected paraaortic lymph nodes of patients with pancreatic adenocarcinoma.
    Ando N; Nakao A; Nomoto S; Takeda S; Kaneko T; Kurokawa T; Nonami T; Takagi H
    Pancreas; 1997 Nov; 15(4):374-8. PubMed ID: 9361091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gene diagnosis of pancreatic adenocarcinoma].
    Wang ZY; Liu TH; Cui QC
    Zhonghua Bing Li Xue Za Zhi; 1994 Oct; 23(5):270-3. PubMed ID: 7874757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of hepatic micrometastasis in pancreatic adenocarcinoma patients by two-stage polymerase chain reaction/restriction fragment length polymorphism analysis.
    Inoue S; Nakao A; Kasai Y; Harada A; Nonami T; Takagi H
    Jpn J Cancer Res; 1995 Jul; 86(7):626-30. PubMed ID: 7559078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peritoneal washing cytology combined with immunocytochemical staining and detecting mutant K-ras in pancreatic cancer: comparison of the sensitivity and availability of various methods.
    Nomoto S; Nakao A; Kasai Y; Inoue S; Harada A; Nonami T; Takagi H
    Pancreas; 1997 Mar; 14(2):126-32. PubMed ID: 9057184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The utility of Ki-ras mutation analysis in the cytologic diagnosis of pancreatobiliary neoplasma.
    Dillon DA; Johnson CC; Topazian MD; Tallini G; Rimm DL; Costa JC
    Cancer J; 2000; 6(5):294-301. PubMed ID: 11079168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative analysis of K-ras gene mutation in pancreatic tissue obtained by endoscopic ultrasonography-guided fine needle aspiration: clinical utility for diagnosis of pancreatic tumor.
    Tada M; Komatsu Y; Kawabe T; Sasahira N; Isayama H; Toda N; Shiratori Y; Omata M
    Am J Gastroenterol; 2002 Sep; 97(9):2263-70. PubMed ID: 12358243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma.
    Wilentz RE; Chung CH; Sturm PD; Musler A; Sohn TA; Offerhaus GJ; Yeo CJ; Hruban RH; Slebos RJ
    Cancer; 1998 Jan; 82(1):96-103. PubMed ID: 9428484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of K-ras gene mutations in plasma DNA of patients with pancreatic adenocarcinoma: correlation with clinicopathological features.
    Yamada T; Nakamori S; Ohzato H; Oshima S; Aoki T; Higaki N; Sugimoto K; Akagi K; Fujiwara Y; Nishisho I; Sakon M; Gotoh M; Monden M
    Clin Cancer Res; 1998 Jun; 4(6):1527-32. PubMed ID: 9626473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemistry and molecular detection of nodal micrometastases in pancreatic cancer.
    Brown HM; Ahrendt SA; Komorowski RA; Doffek KM; Wilson SD; Demeure MJ
    J Surg Res; 2001 Feb; 95(2):141-6. PubMed ID: 11162037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of K-ras and c-erbB-2 mutations in pancreatic adenocarcinoma and chronic pancreatitis.
    Talar-Wojnarowska R; Gasiorowska A; Smolarz B; Romanowicz-Makowska H; Strzelczyk J; Janiak A; Kulig A; Malecka-Panas E
    Int J Gastrointest Cancer; 2005; 35(1):33-41. PubMed ID: 15722572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.